vs
BADGER METER INC（BMI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
BADGER METER INC的季度营收约是Orthofix Medical Inc.的1.1倍（$234.1M vs $219.9M），BADGER METER INC净利率更高（14.3% vs -1.0%，领先15.3%），BADGER METER INC同比增速更快（14.1% vs 2.0%），BADGER METER INC自由现金流更多（$50.8M vs $16.8M），过去两年BADGER METER INC的营收复合增速更高（9.2% vs 8.0%）
Badger Meter Inc是全球领先的流量测量与控制解决方案供应商，主要服务水务企业、工业、商业及住宅客户群体，核心产品包括智能水表、物联网使用监测系统及配套软件，可帮助客户追踪资源消耗、减少浪费、提升运营效率，核心市场覆盖北美、欧洲及亚太地区。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BMI vs OFIX — 直观对比
营收规模更大
BMI
是对方的1.1倍
$219.9M
营收增速更快
BMI
高出12.1%
2.0%
净利率更高
BMI
高出15.3%
-1.0%
自由现金流更多
BMI
多$33.9M
$16.8M
两年增速更快
BMI
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $234.1M | $219.9M |
| 净利润 | $33.6M | $-2.2M |
| 毛利率 | 39.7% | 71.1% |
| 营业利润率 | 18.4% | 0.2% |
| 净利率 | 14.3% | -1.0% |
| 营收同比 | 14.1% | 2.0% |
| 净利润同比 | 9.3% | 92.4% |
| 每股收益（稀释后） | $1.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BMIOFIX
| Q4 25 | $234.1M | $219.9M | ||
| Q3 25 | $222.2M | $205.6M | ||
| Q2 25 | $238.1M | $203.1M | ||
| Q1 25 | $222.2M | $193.6M | ||
| Q4 24 | $205.2M | $215.7M | ||
| Q3 24 | $208.4M | $196.6M | ||
| Q2 24 | $216.7M | $198.6M | ||
| Q1 24 | $196.3M | $188.6M |
净利润BMIOFIX
| Q4 25 | $33.6M | $-2.2M | ||
| Q3 25 | $35.1M | $-22.8M | ||
| Q2 25 | $34.6M | $-14.1M | ||
| Q1 25 | $38.4M | $-53.1M | ||
| Q4 24 | $30.7M | $-29.1M | ||
| Q3 24 | $32.0M | $-27.4M | ||
| Q2 24 | $33.1M | $-33.4M | ||
| Q1 24 | $29.1M | $-36.0M |
毛利率BMIOFIX
| Q4 25 | 39.7% | 71.1% | ||
| Q3 25 | 43.1% | 72.2% | ||
| Q2 25 | 41.1% | 68.7% | ||
| Q1 25 | 42.9% | 62.8% | ||
| Q4 24 | 40.3% | 69.0% | ||
| Q3 24 | 40.2% | 68.7% | ||
| Q2 24 | 39.4% | 67.8% | ||
| Q1 24 | 39.3% | 67.5% |
营业利润率BMIOFIX
| Q4 25 | 18.4% | 0.2% | ||
| Q3 25 | 20.7% | -8.3% | ||
| Q2 25 | 18.8% | -7.9% | ||
| Q1 25 | 22.2% | -25.2% | ||
| Q4 24 | 19.1% | -5.3% | ||
| Q3 24 | 19.5% | -9.6% | ||
| Q2 24 | 19.2% | -12.5% | ||
| Q1 24 | 18.6% | -15.6% |
净利率BMIOFIX
| Q4 25 | 14.3% | -1.0% | ||
| Q3 25 | 15.8% | -11.1% | ||
| Q2 25 | 14.5% | -6.9% | ||
| Q1 25 | 17.3% | -27.4% | ||
| Q4 24 | 15.0% | -13.5% | ||
| Q3 24 | 15.4% | -13.9% | ||
| Q2 24 | 15.3% | -16.8% | ||
| Q1 24 | 14.8% | -19.1% |
每股收益（稀释后）BMIOFIX
| Q4 25 | $1.13 | $-0.05 | ||
| Q3 25 | $1.19 | $-0.57 | ||
| Q2 25 | $1.17 | $-0.36 | ||
| Q1 25 | $1.30 | $-1.35 | ||
| Q4 24 | $1.04 | $-0.76 | ||
| Q3 24 | $1.08 | $-0.71 | ||
| Q2 24 | $1.12 | $-0.88 | ||
| Q1 24 | $0.99 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $713.3M | $450.0M |
| 总资产 | $973.6M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BMIOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务BMIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益BMIOFIX
| Q4 25 | $713.3M | $450.0M | ||
| Q3 25 | $702.5M | $442.5M | ||
| Q2 25 | $677.6M | $458.3M | ||
| Q1 25 | $641.7M | $458.3M | ||
| Q4 24 | $606.2M | $503.1M | ||
| Q3 24 | $591.2M | $525.9M | ||
| Q2 24 | $563.1M | $546.0M | ||
| Q1 24 | $535.6M | $570.3M |
总资产BMIOFIX
| Q4 25 | $973.6M | $850.6M | ||
| Q3 25 | $978.3M | $832.6M | ||
| Q2 25 | $936.4M | $837.2M | ||
| Q1 25 | $899.6M | $823.1M | ||
| Q4 24 | $816.4M | $893.3M | ||
| Q3 24 | $802.9M | $867.9M | ||
| Q2 24 | $781.3M | $882.0M | ||
| Q1 24 | $743.5M | $906.0M |
负债/权益比BMIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $50.8M | $16.8M |
| 自由现金流率自由现金流/营收 | 21.7% | 7.6% |
| 资本支出强度资本支出/营收 | 1.7% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.63× | — |
| 过去12个月自由现金流最近4个季度 | $169.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BMIOFIX
| Q4 25 | $54.8M | $27.7M | ||
| Q3 25 | $51.3M | $12.4M | ||
| Q2 25 | $44.6M | $11.6M | ||
| Q1 25 | $33.0M | $-18.4M | ||
| Q4 24 | $52.1M | $23.7M | ||
| Q3 24 | $45.1M | $11.7M | ||
| Q2 24 | $36.4M | $9.0M | ||
| Q1 24 | $21.5M | $-18.6M |
自由现金流BMIOFIX
| Q4 25 | $50.8M | $16.8M | ||
| Q3 25 | $48.2M | $2.5M | ||
| Q2 25 | $40.6M | $4.5M | ||
| Q1 25 | $30.1M | $-25.1M | ||
| Q4 24 | $47.4M | $15.2M | ||
| Q3 24 | $42.0M | $6.3M | ||
| Q2 24 | $34.1M | $-360.0K | ||
| Q1 24 | $18.8M | $-29.1M |
自由现金流率BMIOFIX
| Q4 25 | 21.7% | 7.6% | ||
| Q3 25 | 21.7% | 1.2% | ||
| Q2 25 | 17.1% | 2.2% | ||
| Q1 25 | 13.5% | -13.0% | ||
| Q4 24 | 23.1% | 7.0% | ||
| Q3 24 | 20.1% | 3.2% | ||
| Q2 24 | 15.7% | -0.2% | ||
| Q1 24 | 9.6% | -15.4% |
资本支出强度BMIOFIX
| Q4 25 | 1.7% | 4.9% | ||
| Q3 25 | 1.4% | 4.8% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 1.3% | 3.5% | ||
| Q4 24 | 2.3% | 4.0% | ||
| Q3 24 | 1.5% | 2.7% | ||
| Q2 24 | 1.1% | 4.7% | ||
| Q1 24 | 1.4% | 5.6% |
现金转化率BMIOFIX
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.29× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 0.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
